Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

COBIMETINIB for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 70 adverse event reports in the FDA FAERS database where COBIMETINIB was used for Neoplasm malignant.

Most Reported Side Effects for COBIMETINIB

Side Effect Reports % Deaths Hosp.
Diarrhoea 412 10.1% 39 214
Off label use 411 10.1% 40 65
Rash 369 9.1% 11 166
Pyrexia 332 8.2% 19 228
Death 231 5.7% 230 23
Nausea 206 5.1% 17 105
Fatigue 198 4.9% 15 93
No adverse event 178 4.4% 0 1
Vomiting 168 4.1% 20 108
Acute kidney injury 133 3.3% 18 114
Photosensitivity reaction 124 3.1% 10 44
Asthenia 119 2.9% 13 68
Rash maculo-papular 118 2.9% 7 73
Blood creatine phosphokinase increased 114 2.8% 5 58
Drug reaction with eosinophilia and systemic symptoms 113 2.8% 6 72

Other Indications for COBIMETINIB

Malignant melanoma (1,324) Metastatic malignant melanoma (898) Product used for unknown indication (402) Histiocytosis (98) Erdheim-chester disease (90) Plasma cell myeloma (76) Neoplasm (68) Langerhans' cell histiocytosis (56) Cholangiocarcinoma (53) Malignant melanoma stage iv (53)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

COBIMETINIB Full Profile All Neoplasm malignant Drugs COBIMETINIB Demographics COBIMETINIB Timeline